Skip to content

A study to explore brain imaging biomarkers for the diagnosis and treatment of patients with early-onset schizophrenia based on prefrontal-thalamic-cerebellar circuits

A study to explore brain imaging biomarkers for the diagnosis and treatment of patients with early-onset schizophrenia based on prefrontal-thalamic-cerebellar circuits

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101232
Enrollment
Unknown
Registered
2025-04-22
Start date
2024-06-26
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Olanzapine treatment case group:None
Normal control group:None

Sponsors

Shandong Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to 18 Years

Inclusion criteria

Inclusion criteria: Case group patients:1. meets DSM-5 diagnostic criteria for schizophrenia; 2. is 13-18 years old, male or female, right-handed; 3. has never received any treatment. Normal control group: age 13-18 years; no mental illness in the family.

Exclusion criteria

Exclusion criteria: 1. Previously or currently meet the DSM-5 diagnostic criteria for other mental illnesses, such as: bipolar disorder, depression, schizoaffective disorder, etc.; 2. Previously taken psychotropic drugs, including antipsychotics, mood stabilizers, etc.; 3. Significant intellectual developmental disorders (IQ <80); 4. Presence of serious physical illnesses, organic brain diseases, such as epilepsy, cardiovascular disease, hepatic and renal disease; 5. People with obvious suicidal tendency; 6. Pregnant or lactating women; 7. People with contraindications to magnetic resonance examination.

Design outcomes

Primary

MeasureTime frame
Positive and Negative Syndrome;Neuropsyc-hological status;

Secondary

MeasureTime frame
Anxiety;Depression;

Countries

China

Contacts

Public ContactShan Xiaoxiao

Shandong Mental Health Center

shanxiaoxiao22@126.com+86 156 6666 4337

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026